Inventor · disambiguated record
Matthew R. Schenauer
Also filed as: SCHENAUER MATTHEW R · SCHENAUER MATTHEW ROBERT
6 granted patents·2 pending applications·22 citations·filing 2018–2023
78Inventor score
Files withGILEAD SCIENCES INC8
Top patents by PatentIndex Score
8 records- 0195US11124582B2FLT3L-FC fusion proteinsGILEAD SCIENCES INC·Filed 2020·Granted Sep 21, 2021·16 cites·1 claims
- 0290US11987617B2Antibodies that target HIV GP120 and methods of useGILEAD SCIENCES INC·Filed 2023·Granted May 21, 2024·1 cites·21 claims
- 0388US11597759B2Multispecific antibodies that target HIV GP120 and CD3GILEAD SCIENCES INC·Filed 2020·Granted Mar 7, 2023·2 cites·14 claims
- 0482US11168130B2Antibodies that target HIV GP120 and methods of useGILEAD SCIENCES INC·Filed 2019·Granted Nov 9, 2021·2 cites·44 claims
- 0575US10882907B2Multispecific antibodies that target HIV GP120 and CD3GILEAD SCIENCES INC·Filed 2018·Granted Jan 5, 2021·1 cites·14 claims
- 0670US12338278B2Antibodies that target HIV gp120 and methods of useGILEAD SCIENCES INC·Filed 2021·Granted Jun 24, 2025·0 cites·24 claims
- 0766US2022049021A1FLT3L-Fc FUSION PROTEINS AND METHODS OF USEGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 0862US2021009718A1FLT3L-Fc FUSION PROTEINS AND METHODS OF USEGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew R. Schenauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →